Archives: Speakers

Baljeet Kaur is an Agriculture Operations Manager (AOM) for U.S. Customs and Border Protection (CBP) at the Boston Field Office (BFO) consisting of six New England States (MA, ME, VT, NH, CT, and RI).  As an AOM, Ms. Kaur is charged with providing guidance to personnel within the BFO on various agriculture matters including, but not limited to: regulated garbage compliance, regulation of biological material, and entry requirements for regulated agriculture commodities.  Ms. Kaur has more than 15 years of public service with CBP, and has worked in a variety of environments including, air passenger, air cargo, and maritime.

Tammi Acord serves as the Director of Strategic Solutions at YPrime, leveraging over two decades of expertise within the Life Sciences sector with roles in commercial (pharmaceutical & medical device), sponsor (pediatric ultra-rare), and vendor (technology) companies. With a proven track record, she excels in developing, leading, executing, and overseeing clinical development programs from inception to commercialization and drug launch. Tammi brings a unique perspective, having navigated the industry’s intricacies across the entire lifecycle, offering valuable insights into the present and future landscape. Based in the vibrant SF/Bay Area, she holds a B.S. from the University of California, Davis.

Derrick Katayama accomplished formulation and analytical scientist with 16 years of experience in the areas of therapeutic proteins, peptides, subunit vaccines, and monoclonal antibodies. He joined Samsung Biologics team in 2022 as a Scientist of Formulation development team in CDO.

Sojeong Lee has over 15 years of biologics process development experience specializing in mammalian cell culture including cell line development, upstream process development and pilot scale manufacturing.

Janet Lee leads Cell Line Development group at Samsung Biologics. Her group has developed over 60 CLD projects successfully including complex biologics. She has over 25 years of biologics drug development experience specializing in Cell Line Development & Upstream Manufacturing Process development from global biotech companies in US. She joined Samsung Biologics team in 2015 as a MSAT Scientist and led number of Tech transfer programs for key commercial biologics.

Daniel Buckley is a Lead Scientist in CDO Downstream at Samsung Biologics. He has an extensive background in the biotech industry, with more than 17 years of experience in new product introductions, purification scale-up, biotech facility design, biotech facility C&Q, process validation, commercial manufacturing, audit readiness, and regulatory inspections. Prior to joining Samsung Biologics, Daniel served as manager for two downstream purification facilities at Eli Lilly.